These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 25356585)
21. Differential cyclooxygenase-2 enzyme expression in radiosensitive versus radioresistant glioblastoma multiforme cell lines. Karim A; McCarthy K; Jawahar A; Smith D; Willis B; Nanda A Anticancer Res; 2005; 25(1B):675-9. PubMed ID: 15816645 [TBL] [Abstract][Full Text] [Related]
22. Molecular evidence of apoptotic death in malignant brain tumors including glioblastoma multiforme: upregulation of calpain and caspase-3. Ray SK; Patel SJ; Welsh CT; Wilford GG; Hogan EL; Banik NL J Neurosci Res; 2002 Jul; 69(2):197-206. PubMed ID: 12111801 [TBL] [Abstract][Full Text] [Related]
23. Localization patterns of cathepsins K and X and their predictive value in glioblastoma. Breznik B; Limback C; Porcnik A; Blejec A; Krajnc MK; Bosnjak R; Kos J; Van Noorden CJF; Lah TT Radiol Oncol; 2018 Oct; 52(4):433-442. PubMed ID: 30367810 [TBL] [Abstract][Full Text] [Related]
24. LncRNA profile of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis. Han L; Zhang K; Shi Z; Zhang J; Zhu J; Zhu S; Zhang A; Jia Z; Wang G; Yu S; Pu P; Dong L; Kang C Int J Oncol; 2012 Jun; 40(6):2004-12. PubMed ID: 22446686 [TBL] [Abstract][Full Text] [Related]
26. Transcriptome Reveals Cathepsin K in Periodontal Ligament Differentiation. Yamada S; Ozaki N; Tsushima K; Yamaba S; Fujihara C; Awata T; Sakashita H; Kajikawa T; Kitagaki J; Yamashita M; Yanagita M; Murakami S J Dent Res; 2016 Aug; 95(9):1026-33. PubMed ID: 27129490 [TBL] [Abstract][Full Text] [Related]
27. Benzyl isothiocyanate alters the gene expression with cell cycle regulation and cell death in human brain glioblastoma GBM 8401 cells. Tang NY; Chueh FS; Yu CC; Liao CL; Lin JJ; Hsia TC; Wu KC; Liu HC; Lu KW; Chung JG Oncol Rep; 2016 Apr; 35(4):2089-96. PubMed ID: 26781422 [TBL] [Abstract][Full Text] [Related]
28. Identification of histological markers for malignant glioma by genome-wide expression analysis: dynein, alpha-PIX and sorcin. Yokota T; Kouno J; Adachi K; Takahashi H; Teramoto A; Matsumoto K; Sugisaki Y; Onda M; Tsunoda T Acta Neuropathol; 2006 Jan; 111(1):29-38. PubMed ID: 16320026 [TBL] [Abstract][Full Text] [Related]
29. Overexpression and localization of cathepsin B during the progression of human gliomas. Sivaparvathi M; Sawaya R; Wang SW; Rayford A; Yamamoto M; Liotta LA; Nicolson GL; Rao JS Clin Exp Metastasis; 1995 Jan; 13(1):49-56. PubMed ID: 7820956 [TBL] [Abstract][Full Text] [Related]
30. Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including acetazolamide in human glioblastoma. Said HM; Hagemann C; Carta F; Katzer A; Polat B; Staab A; Scozzafava A; Anacker J; Vince GH; Flentje M; Supuran CT Bioorg Med Chem; 2013 Jul; 21(13):3949-57. PubMed ID: 23706268 [TBL] [Abstract][Full Text] [Related]
31. Cathepsin K is present in invasive oral tongue squamous cell carcinoma in vivo and in vitro. Bitu CC; Kauppila JH; Bufalino A; Nurmenniemi S; Teppo S; Keinänen M; Vilen ST; Lehenkari P; Nyberg P; Coletta RD; Salo T PLoS One; 2013; 8(8):e70925. PubMed ID: 23951042 [TBL] [Abstract][Full Text] [Related]
32. Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis. Reddy SP; Britto R; Vinnakota K; Aparna H; Sreepathi HK; Thota B; Kumari A; Shilpa BM; Vrinda M; Umesh S; Samuel C; Shetty M; Tandon A; Pandey P; Hegde S; Hegde AS; Balasubramaniam A; Chandramouli BA; Santosh V; Kondaiah P; Somasundaram K; Rao MR Clin Cancer Res; 2008 May; 14(10):2978-87. PubMed ID: 18483363 [TBL] [Abstract][Full Text] [Related]
33. Expression and clinical significance of CPS1 in glioblastoma multiforme. Wu G; Yan Y; Zhou Y; Wang X; Wei J; Chen X; Lin W; Ou C; Zhou J; Xu Z Curr Res Transl Med; 2019 Nov; 67(4):123-128. PubMed ID: 31492588 [TBL] [Abstract][Full Text] [Related]
34. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype. Choe G; Park JK; Jouben-Steele L; Kremen TJ; Liau LM; Vinters HV; Cloughesy TF; Mischel PS Clin Cancer Res; 2002 Sep; 8(9):2894-901. PubMed ID: 12231534 [TBL] [Abstract][Full Text] [Related]
35. Comprehensive analysis of glycolytic enzymes as therapeutic targets in the treatment of glioblastoma. Sanzey M; Abdul Rahim SA; Oudin A; Dirkse A; Kaoma T; Vallar L; Herold-Mende C; Bjerkvig R; Golebiewska A; Niclou SP PLoS One; 2015; 10(5):e0123544. PubMed ID: 25932951 [TBL] [Abstract][Full Text] [Related]
36. Role of Wnt5a in the proliferation of human glioblastoma cells. Yu JM; Jun ES; Jung JS; Suh SY; Han JY; Kim JY; Kim KW; Jung JS Cancer Lett; 2007 Nov; 257(2):172-81. PubMed ID: 17709179 [TBL] [Abstract][Full Text] [Related]
38. Cathepsin D is a potential serum marker for poor prognosis in glioma patients. Fukuda ME; Iwadate Y; Machida T; Hiwasa T; Nimura Y; Nagai Y; Takiguchi M; Tanzawa H; Yamaura A; Seki N Cancer Res; 2005 Jun; 65(12):5190-4. PubMed ID: 15958563 [TBL] [Abstract][Full Text] [Related]
39. Differential expression of MicroRNAs in patients with glioblastoma after concomitant chemoradiotherapy. Park EC; Kim G; Jung J; Wang K; Lee S; Jeon SS; Lee ZW; Kim SI; Kim S; Oh YT; Shin JH; Jang HS; Choi BO; Kim GH OMICS; 2013 May; 17(5):259-68. PubMed ID: 23586679 [TBL] [Abstract][Full Text] [Related]
40. Up-regulation of cathepsin X in prostate cancer and prostatic intraepithelial neoplasia. Nägler DK; Krüger S; Kellner A; Ziomek E; Menard R; Buhtz P; Krams M; Roessner A; Kellner U Prostate; 2004 Jul; 60(2):109-19. PubMed ID: 15162377 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]